Editorial: Post COVID-19: the nucleoside-modified messenger RNA (modRNA) platform.
作者信息
Roncati Luca, Huo Qun Treen
机构信息
Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Department of Laboratory Medicine and Anatomical Pathology, Institute of Pathology, University Hospital of Modena - Polyclinic, Modena, Italy.
出版信息
Front Med (Lausanne). 2024 Jan 4;10:1324610. doi: 10.3389/fmed.2023.1324610. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Post COVID-19: the nucleoside-modified messenger RNA (modRNA) platform.社论：新冠疫情后：核苷修饰信使核糖核酸（modRNA）平台
Front Med (Lausanne). 2024 Jan 4;10:1324610. doi: 10.3389/fmed.2023.1324610. eCollection 2023.
2
Modified mRNA-Based Vaccines Against Coronavirus Disease 2019.基于修饰信使 RNA 的 2019 年冠状病毒病疫苗。
Cell Transplant. 2022 Jan-Dec;31:9636897221090259. doi: 10.1177/09636897221090259.
3
A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination.50岁以上合并症患者在接受mRNA新冠疫苗接种后短期内发生血栓形成死亡的三例系列病例
Pathogens. 2022 Apr 3;11(4):435. doi: 10.3390/pathogens11040435.
4
Nucleoside-modified messenger RNA COVID-19 vaccine platform.核苷修饰的信使 RNA COVID-19 疫苗平台。
J Med Virol. 2021 Jul;93(7):4054-4057. doi: 10.1002/jmv.26924. Epub 2021 Mar 25.
5
Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.系统给予脂质纳米粒以递送修饰的 mRNA 至损伤的心肌。
J Control Release. 2022 Mar;343:207-216. doi: 10.1016/j.jconrel.2022.01.027. Epub 2022 Jan 22.
6
Optimization of Synthesis of Modified mRNA.修饰 mRNA 的合成优化。
Methods Mol Biol. 2022;2573:77-87. doi: 10.1007/978-1-0716-2707-5_7.
7
Direct reprogramming induces vascular regeneration post muscle ischemic injury.直接重编程诱导肌肉缺血损伤后的血管再生。
Mol Ther. 2021 Oct 6;29(10):3042-3058. doi: 10.1016/j.ymthe.2021.07.014. Epub 2021 Jul 29.
8
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.单次接种核苷修饰的 mRNA 疫苗可在小鼠中诱导针对 SARS-CoV-2 的强烈细胞和体液免疫应答。
Immunity. 2020 Oct 13;53(4):724-732.e7. doi: 10.1016/j.immuni.2020.07.019. Epub 2020 Jul 30.
9
GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals.GLA 修饰的 RNA 治疗可降低法布里病患者 iPSC 衍生心肌细胞中的 GB3 水平。
Am J Hum Genet. 2023 Sep 7;110(9):1600-1605. doi: 10.1016/j.ajhg.2023.07.013. Epub 2023 Aug 21.
10
Optimizing Cardiac Delivery of Modified mRNA.优化修饰mRNA的心脏递送
Mol Ther. 2017 Jun 7;25(6):1306-1315. doi: 10.1016/j.ymthe.2017.03.016. Epub 2017 Apr 4.
本文引用的文献
1
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study.新冠疫苗接种后的血栓栓塞事件：一项意大利回顾性真实世界安全性研究。
Vaccines (Basel). 2023 Oct 10;11(10):1575. doi: 10.3390/vaccines11101575.
2
A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults.一项评估基于 mRNA 的基孔肯雅病毒疫苗在健康成年人中的安全性和免疫原性的 1 期、随机、安慰剂对照、剂量范围研究。
Vaccine. 2023 Jun 13;41(26):3898-3906. doi: 10.1016/j.vaccine.2023.04.064. Epub 2023 May 18.
3
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.美国 COVID-19 mRNA 疫苗接种后的心肌炎和心包炎风险：索赔数据库中的队列研究。
Lancet. 2022 Jun 11;399(10342):2191-2199. doi: 10.1016/S0140-6736(22)00791-7.
4
A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination.50岁以上合并症患者在接受mRNA新冠疫苗接种后短期内发生血栓形成死亡的三例系列病例
Pathogens. 2022 Apr 3;11(4):435. doi: 10.3390/pathogens11040435.
5
Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States.向欧洲联盟和美国药物警戒系统报告的 COVID-19 疫苗不良反应的频率和关联性。
Front Public Health. 2022 Feb 3;9:756633. doi: 10.3389/fpubh.2021.756633. eCollection 2021.
6
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗接种与心肌炎或心肌心包炎：基于人群的队列研究
BMJ. 2021 Dec 16;375:e068665. doi: 10.1136/bmj-2021-068665.
7
Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.辉瑞/生物科技或莫德纳 COVID-19 疫苗接种的年轻女性中的血栓栓塞事件。
Expert Opin Drug Saf. 2021 Nov;20(11):1451-1453. doi: 10.1080/14740338.2021.1955101. Epub 2021 Jul 26.
8
Nucleoside-modified messenger RNA COVID-19 vaccine platform.核苷修饰的信使 RNA COVID-19 疫苗平台。
J Med Virol. 2021 Jul;93(7):4054-4057. doi: 10.1002/jmv.26924. Epub 2021 Mar 25.
9
Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.通过细胞文库筛选鉴定的增强 3'UTR 表达提高基于 mRNA 的治疗性基因传递。
Mol Ther. 2019 Apr 10;27(4):824-836. doi: 10.1016/j.ymthe.2018.12.011. Epub 2018 Dec 18.
10
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.核苷修饰的 mRNA 疫苗可诱导强烈的滤泡辅助性 T 细胞和生发中心 B 细胞反应。
J Exp Med. 2018 Jun 4;215(6):1571-1588. doi: 10.1084/jem.20171450. Epub 2018 May 8.
Zotero 插件